Surface modification of poly (l-lactic acid) microspheres for site-specific delivery of ketoprofen for chronic inflammatory disease

References

• Carsons S, Lavietes BB, Diamond HS. (1989). Role of fibronectin in rheumatic diseases. In: Mosher DF, ed. Fibronectin. San Diego: Academic Press, 218–232.
   Google Scholar
• Chi SC, Jun HW. (1990). Anti-inflammatory activity of ketoprofen gel on carrageenan-induced paw edema in rats. J Pharm Sci, 79, 974–977.
   PubMed Web of Science ®Google Scholar
• Colvin RB. (1989). Fibronectin in wound healing. In: Mosher DF, ed. Fibronectin. San Diego: Academic Press, 201–218.
   Google Scholar
• Gandini R, Cunietti E, Pappalepore V, Ferrari M, Deleo B, Locatelli E, Fasoli A, Liverta C. (1983). Effects of intravenous high doses of ketoprofen on blood clotting, bleeding time and platelet aggregation in man. J Int Med Res, 11, 243–246.
   PubMed Web of Science ®Google Scholar
• Groves MJ. (1999). Parenteral drug delivery systems. In: Mathiowitz E, ed. Encyclopedia of Controlled Drug Delivery. Vol 1. New York: John Wiley & Sons, 743–777.
   Google Scholar
• Gürol Z, Hekimoglu S, Demirdamar R, Sumnu M. (1996). Percutaneous absorption of ketoprofen. I. In vitro release and percutaneous absorption of ketoprofen from different ointment bases. Pharm Acta Helv, 71, 205–212.
   PubMedGoogle Scholar
• Henmi T, Fujii M, Kikuchi K, Yamanobe N, Matsumoto M. (1994). Application of an oily gel formed by hydrogenated soybean phospholipids as a percutaneous absorption-type ointment base. Chem Pharm Bull, 42, 651–655.
   PubMed Web of Science ®Google Scholar
• Hynes RO. (1990). Fibronectins. New York: Springer-Verlag, 113–145.
   Google Scholar
• Jamie M, Sung T, Diane JB. (2001). Preparation and characterization of gelatin surface modified PLGA microspheres. AAPS Pharm Sci, 3, 1–11. DOI: 10.1208/ps030111.
   PubMedGoogle Scholar
• Kheradmandnia S, Vasheghani-Farahani E, Nosrati M, Atyabi F. (2010). Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax. Nanomedicine, 6, 753–759.
   PubMed Web of Science ®Google Scholar
• Liang LS, Jackson J, Min W, Risovic V, Wasan KM, Burt HM. (2004). Methotrexate loaded poly(L-lactic acid) microspheres for intra-articular delivery of methotrexate to the joint. J Pharm Sci, 93, 943–956.
   PubMed Web of Science ®Google Scholar
• Lou Y, Olson WP, Tian XX, Klegerman ME, Groves MJ. (1995). Interaction between fibronectin-bearing surfaces and Bacillus Calmette-Guérin (BCG) or gelatin microparticles. J Pharm Pharmacol, 47, 177–181.
   PubMed Web of Science ®Google Scholar
• Noda K, Nakagawa A, Yamagata T, Ide H. (1983). Anti-inflammatory and analgesic gel composition. US Patent, 4, 393, 076.
   Google Scholar
• Patil P, Joshi P. (2004). Effect of formulation variable on preparation and evaluation of gelled self-emulsifying drug delivery system of ketoprofen. AAPS Pharm Sci Tech, 3, 42.
   Google Scholar
• Perrin DA, English JP. (1997). Polyglycolide and polylactide. In: Domb AJ, Kost J, Wiseman DM, eds. Handbook of Biodegradable Polymers. Amsterdam: Harwood Academic Publishers, 3–25.
   Google Scholar
• Podlogar F, Bester Rogac M, Gasperlin M. (2005). The effect of internal structure of selected water-Tween 40-Imwitor 308-IPM microemulsions on ketoprofene release. Int J Pharm, 302, 68–77.
   PubMed Web of Science ®Google Scholar
• Pouton CW. (2000). Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci, 11 Suppl 2, S93–S98.
   PubMed Web of Science ®Google Scholar
• Pouton CW. (2006). Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci, 29, 278–287.
   PubMed Web of Science ®Google Scholar
• Ruan G, Feng SS. (2003). Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials, 24, 5037–5044.
   PubMed Web of Science ®Google Scholar
• Scholes PD, Coombes AGA, Davies MC, Illum I, Davis SS. (1997). Particle engineering of biodegradable colloids for site-specific drug delivery. In: Park K, ed. Controlled Drug Delivery: Challenges and Strategies. Washington, DC: American Chemical Society, 73–106.
   Google Scholar
• Stolnik S, Dunn SE, Garnett MC, Davies MC, Coombes AG, Taylor DC, Irving MP, Purkiss SC, Tadros TF, Davis SS. (1994). Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm Res, 11, 1800–1808.
   PubMed Web of Science ®Google Scholar
• Streubel A, Siepmann J, Bodmeier R. (2003). Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles. J Microencapsul, 20, 329–347.
   PubMed Web of Science ®Google Scholar
• Tamura T, Imai J, Matsumoto A, Tanimoto M, Suzuki A, Horikiri Y, Suzuki T, Yoshino H, Ike O. (2002). Organ distribution of cisplatin after intraperitoneal administration of cisplatin-loaded microspheres. Eur J Pharm Biopharm, 54, 1–7.
   PubMed Web of Science ®Google Scholar
• Thompson PN, Cho E, Blumenstock FA, Shah DM, Saba TM. (1992). Rebound elevation of fibronectin after tissue injury and ischemia: role of fibronectin synthesis. Am J Physiol, 263, G437–G445.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (2006). Nanoparticulates as drug carriers. London, Imperial college press, 125–172.
   Google Scholar
• Tsung MJ, Burgess DJ. (2001). Preparation and characterization of gelatin surface modified PLGA microspheres. AAPS PharmSci, 3, 14–24.
   Google Scholar
• Yaw-Bin H, Ren-Jiunn W, Jui-Sheng C, Yi-Hung T, Pao-Chu W. (2007). Evaluation of ketoprofen formulations via penetration rate and irritation in vivo study. Int J Pharm, 339, 47–51.
   PubMedGoogle Scholar
• Yun-Seok R, Jung-Gyo C. (2001). Transdermal delivery of ketoprofen using microemulsions. Int J Pharm, 228, 61–170.
   Google Scholar